Physician profile
George P Thomas
NPI 1649293150
$1,108.39
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $273 · 2020: $245 · 2021: $300 · 2022: $133 · 2023: $91.15 · 2024: $66.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $157.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $523.29 | 2019-2021 | |
| Abbvie INC. | $222.91 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $115.44 | 2019-2024 | Xifaxan, Trulance |
| Merck Sharp & Dohme LLC | $42.95 | 2021 | |
| Blueprint Medicines Corporation | $37.56 | 2023 | Ayvakit |
| Intercept Pharmaceuticals, INC. | $25.08 | 2022 | |
| Eisai INC. | $24.81 | 2019 | |
| Exact Sciences Corporation | $22.43 | 2023 | Cologuard Collection Kit |
| Madrigal Pharmaceuticals | $21.86 | 2024 | Resmetirom |
| Takeda Pharmaceuticals U.S.A., INC. | $21.60 | 2024 | Entyvio |
| W. L. Gore & Associates, INC. | $18.44 | 2022 | |
| Dova Pharmaceuticals | $16.14 | 2019 | |
| Djo, LLC | $15.88 | 2023 | Cmf |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.